Most people treat this as a shopping decision. It isn’t. It’s a medical one dressed up in a checkout flow. The company you choose determines which drug you get, who reviews your labs, whether you’re talking to an obesity specialist or a general practitioner, and what happens when you hit a plateau. The platform matters more than most comparison guides admit.
Here’s how to actually decide, with real companies mapped to real criteria.
First, Ask Yourself Five Questions
Before any brand enters your thinking, sort yourself into a category:
- Do you have insurance that might cover branded GLP-1s?
- Are you comfortable with compounded medications, understanding they are not FDA-approved?
- Do you want ongoing coaching or just a prescription?
- Are you interested in other peptide therapies alongside or instead of semaglutide or tirzepatide?
- What’s your actual monthly budget, medication included?
Your answers filter out most of these companies immediately. The ten below represent ten genuinely different models.
Criterion 1: Insurance Navigation
If you have commercial insurance with any chance of GLP-1 coverage, the platform’s ability to fight for prior authorization is worth real money. We’re talking about drugs that can cost $1,000-plus per month at retail.
Ro (Ro Body) has a dedicated prior-authorization team. Membership starts around $39 for the first month, roughly $74 monthly on an annual plan, and medication is billed separately once approved. Polished app, established clinical process.
Calibrate leans even harder into the insurance track. It charges a program fee on top of medication and requires a 12-month commitment, but that structure exists because it’s designed for patients working through insurer approval with sustained coaching.
PlushCare keeps overhead low, about $19.99 per month for app access, and accepts insurance on prescriptions for Ozempic, Wegovy, and Mounjaro. Same-day appointments are available. Good for someone who already has a sense of what they want and just needs a prescriber in their corner.
Criterion 2: Specialist-Level Clinical Oversight
Not every telehealth provider uses the same type of clinician. This gap is larger than it looks.
Mochi Health uses board-certified obesity-medicine specialists. That’s a specific credential. Compounded semaglutide runs about $99 per month, compounded tirzepatide around $199, with discounts on longer commitments. For patients who want more than a rubber-stamp prescription, this structure offers more clinical texture.
Form Health pairs physicians with registered dietitians. It’s expensive, around $299 per month before labs and medication, but the model is genuinely different. Best fit for patients with complex metabolic histories or the budget to pay for a higher-touch experience.
Criterion 3: Cash-Pay Simplicity
Some people don’t want memberships, coach check-ins, or an app subscription. They want a prescription at a known price.
Henry Meds fills this role cleanly. Compounded programs, fast shipping, first-month pricing in the $179-249 range. Clinical monitoring is lighter than some of the specialist-led platforms, which matters if you need ongoing labs reviewed.
Eden runs compounded semaglutide at roughly $149 per month cash-pay. Straightforward.
MEDVi charges around $179 for the first month with no membership fee stacked on top and includes physician review and round-the-clock support. No contracts.
Criterion 4: Behavior Change as the Core Product
Medication without habit change produces temporary results. Some programs are built around that fact.
WeightWatchers Clinic brings its behavior-change infrastructure to GLP-1 prescribing, about $74 per month for the program with medication billed separately. The brand’s strength is decades of structured behavior support.
Found takes a coaching-plus-medication approach at about $99 per month for platform access. It won’t be the right fit for people who just want the drug, but it’s a reasonable option for people who want accountability alongside it.
Criterion 5: Budget-Friendly Marketplace Access
Sesame (Success by Sesame) uses a marketplace model that can get monthly costs down to about $59 on an annual plan. Telehealth visits and unlimited messaging are included. Medication is billed separately. It’s not a clinical program in the Mochi or Form Health sense, but for price-conscious patients, the structure is real and transparent.
Criterion 6: Breadth of Catalog and Transparent Testing
This criterion matters specifically if you’re trying to learn GLP-1 options alongside other peptide therapies, not just as a standalone weight drug.
Most weight-loss telehealth companies offer semaglutide or tirzepatide and nothing else. Most peptide vendors sell research compounds with no prescriber involved at all. Very few operations sit in between.
FormBlends is one of the exceptions. It’s a prescription-based telehealth model covering 47 states, dispensed through a pharmacy with a licensed physician signing each order. The reason it earns a mention here is specificity. The pharmacy that fills it publishes per-product purity figures for every compound in the catalog. Semaglutide comes in at 99.1% purity. Tirzepatide at 99.3%. Those aren’t marketing claims; they’re batch-level numbers. Pricing is posted flat, no membership bundled on top: semaglutide at $299 per vial, tirzepatide at $349. The catalog also includes GH peptides, nootropic peptides, and recovery compounds, most of which carry only preclinical or early-stage human evidence and should be treated accordingly. Not FDA-approved. Worth knowing about if your interest in GLP-1s connects to a broader interest in peptide pharmacology.
Criterion 7: Big-Brand Convenience
Hims and Hers is the most recognizable name here. After a settlement in early 2026, it moved new patients to branded medications only. Injectable Wegovy runs about $299 per month, oral Wegovy around $249, Zepbound around $399. With commercial insurance and a savings card, some patients pay as little as nothing. The app experience is slick and onboarding is fast. If you want a known name and a smooth process, this is the obvious pick.
A Final Word Before You Decide
Every platform above involves prescription medication affecting hormone pathways, metabolic function, or both. Before committing, verify that your chosen provider will monitor labs, adjust dosing, and actually answer clinical questions when something feels off. A cheap monthly fee that comes with no medical follow-up is not a deal.
Before starting any GLP-1 or peptide program, go over your full health history with a qualified clinician who knows your case. This article is informed editorial opinion, not a substitute for that conversation.
Sources
- FDA (fda.gov): GLP-1 drug approvals, compounding regulations, warning letters
- Examine.com: semaglutide, tirzepatide, peptide research summaries
- Cleveland Clinic: GLP-1 receptor agonist overview
- Verywell Health: telehealth weight-loss platform comparisons
- GoodRx: retail prices for brand-name GLP-1 drugs and manufacturer savings card details
- Drugs.com: drug class and mechanism reference
- Healthline: obesity-medicine specialist credential explainer
[internal: placement Passing mention | structure: Decision-guide framing, criteria-first]
